Rafferty Asset Management
BEAM icon

Rafferty Asset Management’s Beam Therapeutics BEAM Stock Holding History

Rafferty Asset Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Sell
93,606
-79,342
-46% -$2.4M 0.01% 520
2026
Q1 		$4.12M Sell
172,948
-3,911
-2% -$109K 0.02% 452
2025
Q4 		$4.9M Buy
176,859
+39,707
+29% +$1.01M 0.02% 439
2025
Q3 		$3.33M Buy
137,152
+14,320
+12% +$285K 0.01% 526
2025
Q2 		$2.09M Buy
122,832
+2,961
+2% +$51.6K 0.01% 597
2025
Q1 		$2.34M Buy
119,871
+8,771
+8% +$230K 0.01% 533
2024
Q4 		$2.76M Sell
111,100
-75,991
-41% -$1.94M 0.01% 552
2024
Q3 		$4.58M Buy
187,091
+21,827
+13% +$564K 0.02% 441
2024
Q2 		$3.87M Sell
165,264
-79,090
-32% -$1.94M 0.01% 474
2024
Q1 		$8.07M Sell
244,354
-95,363
-28% -$2.97M 0.03% 343
2023
Q4 		$9.25M Sell
339,717
-424
-0.1% -$10.5K 0.04% 302
2023
Q3 		$8.18M Buy
340,141
+82,150
+32% +$2.2M 0.05% 279
2023
Q2 		$8.24M Buy
257,991
+46,323
+22% +$1.5M 0.05% 261
2023
Q1 		$6.48M Buy
211,668
+16,943
+9% +$669K 0.04% 317
2022
Q4 		$7.62M Buy
194,725
+70,800
+57% +$3.17M 0.06% 275
2022
Q3 		$5.9M Buy
123,925
+2,952
+2% +$168K 0.06% 297
2022
Q2 		$4.68M Buy
120,973
+30,590
+34% +$1.22M 0.04% 286
2022
Q1 		$5.18M Buy
90,383
+16,604
+23% +$1.09M 0.03% 384
2021
Q4 		$5.88M Buy
73,779
+45,173
+158% +$3.87M 0.03% 312
2021
Q3 		$2.49M Sell
28,606
-784
-3% -$78.8K 0.02% 565
2021
Q2 		$3.78M Sell
29,390
-4,464
-13% -$356K 0.02% 425
2021
Q1 		$2.71M Buy
33,854
+23,029
+213% +$2.19M 0.02% 545
2020
Q4 		$884K Buy
+10,825
New +$532K 0.01% 535

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Rafferty Asset Management's BEAM Position: Q2 2026 in Review

Rafferty Asset Management reduced its Beam Therapeutics (BEAM) stake by 46% in Q2 2026, selling an estimated $2.4M and leaving 93,606 shares worth $3.21M. The position accounts for 0.01% of the portfolio, ranked #520.

Rafferty Asset Management first reported a position in BEAM in Q4 2020 and has held it in 23 quarters since. The position peaked at $9.25M in Q4 2023. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Rafferty Asset Management held 93,606 shares of Beam Therapeutics worth $3.21M as of Q2 2026.
  • Rafferty Asset Management sold 79,342 Beam Therapeutics shares in Q2 2026, an estimated $2.4M.
  • Beam Therapeutics made up 0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #520 holding.
  • Rafferty Asset Management first reported a position in Beam Therapeutics in Q4 2020 and has held it in 23 quarters since.
  • Rafferty Asset Management's Beam Therapeutics position peaked at $9.25M in Q4 2023.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.